IDXXIdexx LaboratoriesHealth Care
$554.99EarningsNov 2, 2026
1D—1W—1M—3M—1Y—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▼ −13.0% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E40.9×2127
39
76
P / S10.1×912
8
18
P / FCF41.5×1716
41
90
EV / EBITDA30.0×1314
27
57
P / E (fwd)37.6×——
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin62.1%7255
59%
62%
Operating margin31.6%8689
26%
32%
Net margin24.6%8588
20%
25%
ROE71.8%9594
57%
118%
ROIC44.3%9796
34%
49%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.635248
0.5
3.0
Net debt / EBITDA0.5×6563
Current ratio1.123616
Interest coverage35.5×8375
Per shareTTM, with year-over-year change
Revenue / share$55.11▲ +13%
EPS (diluted)$13.56▲ +25%
FCF / share$13.38▲ +29%
Est. EPS growth (fwd)+14%